title: President's address of the 65th annual scientific meeting of the Japanese Association for Thoracic Surgery: challenges for advanced esophageal cancer.
abstract: Advanced esophageal tumors have been a challenge for surgery since the very beginning, and these challenges continue still today. In the early period of three-field lymphadenectomy (late 1980s), there was no special attention paid to tracheal necrosis after such an extended operation. In 1988, we reported functional mediastinal dissection preserving the right bronchial artery to prevent such complications. In 1993, we reported that the survival after three-field lymphadenectomy was better than that after en-bloc esophagectomy, and then the lymph node compartment classification based on the metastatic rate and the survival rate. This concept was introduced into the 9th edition of the Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus published in 1999. In early 1980s, combined resection of the neighboring organs was initiated for a locally advanced esophageal cancer. Almost all patients who underwent such an operation, however, died of metastasis in the short-term after surgery without any additional treatment. In 1987, we reported several types of tracheal repair using the latissimus dorsi muscle flap, as a less-invasive surgery that enabled adjuvant or additive therapy, after resection of the trachea involved by cancer. Then in 2004, we demonstrated that the canine aorta could be resected even immediately after aortic stenting. This suggests that an esophageal cancer involving the aorta can be resected using a new technique. To meet the challenges posed by advanced esophageal cancer, the help of other specialized fields besides esophageal surgery is needed: "The specialist must know everything of something, something of everything."
authors: Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan. fujita@med.kurume-u.ac.jp
authors: Hiromasa
authors: H
authors: Fujita
mesh_terms: D000818:Animals; D059248:Chemoradiotherapy / Q000266:history; D004938:Esophageal Neoplasms / Q000266:history* / Q000628:therapy; D016629:Esophagectomy / Q000266:history* / Q000379:methods / Q000639:trends; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008197:Lymph Node Excision / Q000266:history* / Q000379:methods; D015996:Survival Rate
references: Am J Surg. 1981 Feb;141(2):216-8
references: 7457740
references: Jpn J Surg. 1987 Mar;17(2):91-8
references: 3626209
references: Oncology. 1991;48(5):411-20
references: 1745490
references: Ann Surg. 1995 Nov;222(5):654-62
references: 7487213
references: Jpn J Surg. 1988 Jan;18(1):31-4
references: 3386070
references: World J Surg. 2003 May;27(5):571-9
references: 12715226
references: Ann Thorac Surg. 1991 Jun;51(6):931-5
references: 2039322
references: Jpn J Thorac Cardiovasc Surg. 2004 May;52(5):231-9
references: 15195745
references: Jpn J Thorac Cardiovasc Surg. 1999 Dec;47(12):611-6
references: 10658379
references: World J Surg. 2005 Jan;29(1):25-30; discussion 30-1
references: 15599735
references: Jpn J Surg. 1988 Jan;18(1):77-83
references: 3386074
references: Ann Surg. 1994 Sep;220(3):364-72; discussion 372-3
references: 8092902
references: J Clin Oncol. 1999 Sep;17(9):2915-21
references: 10561371
references: J Surg Oncol. 2005 Jun 15;90(4):209-19
references: 15906363
references: Nihon Kyobu Geka Gakkai Zasshi. 1987 Jan;35(1):35-41
references: 3572121
references: Dis Esophagus. 2011 Nov;24(8):E36-40
references: 21883655
references: Jpn J Surg. 1987 May;17(3):217-9
references: 3306077
references: Nihon Geka Gakkai Zasshi. 1984 Jan;85(1):17-28
references: 6738487